European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties meeting with all eligible organisations

This meeting brings together all eligible patient and consumer and healthcare professionals organisations and members of the Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Party (HCPWP).

The meeting focuses on the following topics:

• Patient involvement in medicines development and regulation including feedback from Patient Experience Data workshop and CIOMS report
• Update from Task Force on availability of authorised medicines
• Health Technology Assessment – interconnection of regulatory and HTA activities and role of patients and HCP
• Future activities on antimicrobial resistance.

Report from EMA Multistakeholder Workshop on Patient Experience Data - Rosa Gonzalez-Quevedo (EMA)

CIOMS report on ‘Patient involvement in the development, regulation and safe use of medicines’ - François Houÿez (EURORDIS) & Lembit Rägo (CIOMS)

Update on the TF AAM activities - Monica Dias (EMA) & Hugues Malonne (HMA)

Reporting of shortages by organisations - Inga Abed (EMA)

Preparation for multistakeholder workshop in 2023 - Monica Dias (EMA)

Update on EU guidance on shortage prevention and communication to the public - Inga Abed (EMA)

Implementation of Regulation (EU) 2021/2282 on Health Technology Assessment - Valentina Barbuto (EC)

“Sequential decision making”: how regulatory and HTA activities interconnect under the new HTA Regulation - Michael Berntgen (EMA)

The delivery under the EMA/EUnetHTA 21 work plan: focus on engagement with patients and HCPs - regulatory and HTA activities interconnect under the new HTA Regulation
3:50:00 – 4:10:31 Stephanie

Lessons learnt from COVID - 19 Melanie Carr (EMA)

Preparation for multistakeholder workshop on AMR in 2023 - Radu Botgros (EMA) & Ivana Silva (EMA)